IL135581A0 - Novel use of compounds for anti-pruritic activity - Google Patents

Novel use of compounds for anti-pruritic activity

Info

Publication number
IL135581A0
IL135581A0 IL13558198A IL13558198A IL135581A0 IL 135581 A0 IL135581 A0 IL 135581A0 IL 13558198 A IL13558198 A IL 13558198A IL 13558198 A IL13558198 A IL 13558198A IL 135581 A0 IL135581 A0 IL 135581A0
Authority
IL
Israel
Prior art keywords
compounds
novel use
pruritic activity
pruritic
activity
Prior art date
Application number
IL13558198A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL135581A0 publication Critical patent/IL135581A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13558198A 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity IL135581A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6374697P 1997-10-17 1997-10-17
PCT/US1998/021886 WO1999020280A1 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Publications (1)

Publication Number Publication Date
IL135581A0 true IL135581A0 (en) 2001-05-20

Family

ID=22051225

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13558198A IL135581A0 (en) 1997-10-17 1998-10-16 Novel use of compounds for anti-pruritic activity

Country Status (18)

Country Link
EP (1) EP1030666A4 (de)
JP (1) JP2001520196A (de)
KR (1) KR20010031149A (de)
CN (1) CN1306426A (de)
AR (1) AR015966A1 (de)
AU (1) AU740875B2 (de)
BR (1) BR9814080A (de)
CA (1) CA2306985A1 (de)
CO (1) CO4810374A1 (de)
CZ (1) CZ20001376A3 (de)
HU (1) HUP0003792A3 (de)
IL (1) IL135581A0 (de)
NO (1) NO20001847L (de)
NZ (1) NZ503551A (de)
PL (1) PL341062A1 (de)
TR (1) TR200001040T2 (de)
WO (1) WO1999020280A1 (de)
ZA (1) ZA989450B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1355884A1 (de) 2001-01-31 2003-10-29 Pfizer Products Inc. Nicotinamidbiarylderivate, die sich als inhibitoren von pde4-isozymen eignen
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
WO2002060898A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
IL156460A0 (en) 2001-01-31 2004-01-04 Pfizer Prod Inc Ether derivatives useful as inhibitors of pde4 isozymes
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
EP1647274A4 (de) * 2003-07-17 2008-12-10 Ono Pharmaceutical Co Mittel zur behandlung von pruritus mit einem piperidin-derivat als wirkstoff
WO2005053672A1 (ja) * 2003-12-04 2005-06-16 Santen Pharmaceutical Co., Ltd. シロミラストまたはその塩を有効成分とする掻痒治療剤
JP2005187458A (ja) * 2003-12-04 2005-07-14 Santen Pharmaceut Co Ltd シロミラストまたはその塩を有効成分とする掻痒治療剤
EP1781657B1 (de) 2004-02-14 2013-03-27 GlaxoSmithKline Intellectual Property Development Limited Medikamente mit wirkung am hm74a-rezeptor
JP2008137892A (ja) * 2005-03-04 2008-06-19 Eisai Co Ltd 止痒剤
PL1912991T3 (pl) 2005-08-10 2011-04-29 Glaxosmithkline Llc Pochodne ksantyny jako selektywni agoniści receptora HM74A
TWI404709B (zh) * 2006-02-21 2013-08-11 Eisai R&D Man Co Ltd 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives
MX2008010774A (es) * 2006-02-21 2008-09-01 Eisai R&D Man Co Ltd Derivados de 4-(3-benzoilaminofenil)-6, 7-dimetoxi-2-metilaminoqui nazolina.
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル ｎ－［３－（６，７－ジメトキシ－２－メチルアミノキナゾリン－４－イル）フェニル］テレフタラミックアシッドの結晶、非晶質体または塩
JP5060561B2 (ja) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規外用剤
EP2189450B1 (de) 2007-08-17 2011-12-21 Eisai R&D Management Co., Ltd. Verfahren zur herstellung eines chinazolinderivats
US20140121240A1 (en) * 2011-06-28 2014-05-01 Maruho Co., Ltd. Novel pharmaceutical composition
EA034139B1 (ru) 2015-01-30 2020-01-09 Шаньтонь Фарма Ко., Лтд. Профилактика или лечение мочекислых или подагрических заболеваний

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563168B1 (de) * 1990-12-21 2000-07-05 Beecham Group Plc Xanthinderivate
WO1997035854A1 (de) * 1996-03-26 1997-10-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue in 6-position substituierte phenanthridine
ATE228131T1 (de) * 1996-05-15 2002-12-15 Altana Pharma Ag Imidazopyridine
ATE248167T1 (de) * 1997-03-07 2003-09-15 Altana Pharma Ag Tetrazole derivate
ID22975A (id) * 1997-03-18 1999-12-23 Basf Ag Metode dan komposisi untuk memodulasi respons terhadap kortikosteroid
AU8106598A (en) * 1997-06-03 1998-12-21 Byk Gulden Lomberg Chemische Fabrik Gmbh Benzonaphthyridine

Also Published As

Publication number Publication date
TR200001040T2 (tr) 2001-01-22
CZ20001376A3 (cs) 2002-06-12
BR9814080A (pt) 2000-09-26
HUP0003792A3 (en) 2001-12-28
KR20010031149A (ko) 2001-04-16
CO4810374A1 (es) 1999-06-30
HUP0003792A2 (hu) 2001-10-28
CA2306985A1 (en) 1999-04-29
NO20001847D0 (no) 2000-04-10
JP2001520196A (ja) 2001-10-30
NZ503551A (en) 2002-05-31
PL341062A1 (en) 2001-03-26
AU740875B2 (en) 2001-11-15
CN1306426A (zh) 2001-08-01
EP1030666A1 (de) 2000-08-30
ZA989450B (en) 1999-04-19
AU1093899A (en) 1999-05-10
NO20001847L (no) 2000-04-10
WO1999020280A1 (en) 1999-04-29
AR015966A1 (es) 2001-05-30
EP1030666A4 (de) 2002-10-16

Similar Documents

Publication Publication Date Title
IL134086A0 (en) Novel spiroazabicyclic heterocyclic compounds
ZA989450B (en) Novel use of compounds for anti-pruritic activity
EG24412A (en) Novel compounds
EG24041A (en) New heterocyclic compounds
EG24177A (en) Novel compounds
CZ219999A3 (cs) Nové sloučeniny s analgetickým účinkem
PL340400A1 (en) 2-phenyl-substituted imidazotriazinones as inhibitors of phosphodiesterase
IL132170A0 (en) Novel heterocyclic compounds
CZ220099A3 (cs) Nové sloučeniny s analgetickým účinkem
GB9701684D0 (en) Novel compounds
PL337738A1 (en) Novel substituted compounds of imidazole
GB9706255D0 (en) Novel compounds
PL338791A1 (en) Compounds exhibiting neuronic activity
IL113248A0 (en) Use of alpha - 1c specific compounds
IL125840A0 (en) Production of bromine compounds
GB9701674D0 (en) Use of organic compounds
ZA981920B (en) Novel heterocyclic compounds
HU9800373D0 (en) Steroide compounds of anticeptive and antiosteoporosive activity
ZA988681B (en) Novel compounds
PL339673A1 (en) Novel compounds suitable for use as neuroprotective agents
ZA985448B (en) Novel heterocyclic compounds
HU9700442D0 (en) Compounds of pharmaceutical activity
ZA983800B (en) Novel heterocyclic compounds
AUPP059897A0 (en) New use of bicozamycin
GB9722026D0 (en) Use of compounds